Hyun-Ki Kim Chan-Jeoung Park Seongsoo Jang Young-Uk Cho Sang Hyuk Park Jene Choi Chan-Sik Park Jooryung Huh Young-Hwa Chung Jung-Hee Lee
10.3343/alm.2015.35.1.152
Ann Lab Med
2015 Jan;35(1):152-4.
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/25553299/
Bone Marrow / pathology Lymphoma, Large B-Cell, Diffuse / diagnosis Lymphoma, T-Cell, Peripheral / diagnosis
Bone Marrow / pathology Lymphoma, Large B-Cell, Diffuse / diagnosis Lymphoma, T-Cell, Peripheral / diagnosis Case Reports Letter Antibodies, Monoclonal, Murine-Derived / therapeutic use Antineoplastic Combined Chemotherapy Protocols / therapeutic use Bone Marrow / metabolism Cyclophosphamide / therapeutic use Doxorubicin / therapeutic use Endoscopy, Digestive System Female Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor Genetic Loci Humans Liver / metabolism Liver / pathology Lymphocytes / cytology Lymphocytes / immunology Lymphoma, Large B-Cell, Diffuse / complications Lymphoma, Large B-Cell, Diffuse / drug therapy Lymphoma, T-Cell, Peripheral / complications Lymphoma, T-Cell, Peripheral / drug therapy Middle Aged PAX5 Transcription Factor / metabolism Prednisone / therapeutic use Receptors, Antigen, T-Cell, gamma-delta / genetics Rituximab Tomography, X-Ray Computed Vincristine / therapeutic use Antibodies, Monoclonal, Murine-Derived PAX5 Transcription Factor PAX5 protein, human R-CHOP protocol Receptors, Antigen, T-Cell, gamma-delta Rituximab Vincristine Doxorubicin Cyclophosphamide Prednisone
PMC4272950
25553299
The first case report of composite bone marrow involvement by simultaneously developed peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma
2015